Fair values of financial instruments carried at fair value (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Fair Value Measurement [Abstract] |
|
Disclosure of fair value measurement of assets |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | | | | | | | | | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | Transfers between Level 1 and Level 2 fair values | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised (losses)/gains recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(expense) from other financial instruments designated at fair value | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments (continued) | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 30 Jun 2024 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
| | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held 31 Dec 2024 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
1Financial investments assets include £0.9bn of transfers out relating to enhancement of observability assessments on commercial paper. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value and bases of valuation – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
|
Disclosure of fair value measurement of liabilities |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation | | | | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | Quoted market price Level 1 | Using observable inputs Level 2 | With significant unobservable inputs Level 3 | | | | | | | | | | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | | Financial instruments carried at fair value and bases of valuation – assets and liabilities held for sale | | | | | | | | | | | | | | | | | | | | | | Recurring fair value measurements | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities designated at fair value | | | | | | | | | | | | | | | | | |
| | | | | | | | Transfers between Level 1 and Level 2 fair values | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | | | | | | | | | | | | | | | | | | Transfers from Level 1 to Level 2 | | | | | | | | Transfers from Level 2 to Level 1 | | | | | | | |
| | | | | | | | | | Financial instruments measured at fair value using a valuation technique with significant unobservable inputs – Level 3 | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised (losses)/gains recognised in profit or loss relating to assets and liabilities held at 30 Jun 2025 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(expense) from other financial instruments designated at fair value | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Movement in Level 3 financial instruments (continued) | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 30 Jun 2024 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
| | | | | | | | | | | | | | | | Total gains/(losses) on assets and total (gains)/losses on liabilities recognised in profit or loss | | | | | | | | – net income from financial instruments held for trading or managed on a fair value basis | | | | | | | | – net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | | – gains from financial investments at fair value through other comprehensive income | | | | | | | | Total losses recognised in other comprehensive income | | | | | | | | – financial investments: fair value gains | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held 31 Dec 2024 | | | | | | | | – trading (expense)/income excluding net interest income | | | | | | | | – net income/(losses) from financial instruments held for trading or managed on a fair value basis | | | | | | | | – changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | | | | |
1Financial investments assets include £0.9bn of transfers out relating to enhancement of observability assessments on commercial paper. | | | | | Fair values of financial instruments not carried at fair value on the balance sheet | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
| | | | | Fair values of financial instruments not carried at fair value and bases of valuation – assets and disposal groups held for sale | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | | | | Loans and advances to customers | | | | | Reverse repurchase agreements – non-trading | | | | | Financial investments – at amortised cost | | | | | | | | | | | | | | | | | | | | Repurchase agreements – non-trading | | | | | | | | | | | | | | |
|
Disclosure of fair value adjustments on financial instruments |
| | | | | | | | | | | | | | | | | | | | | | – credit valuation adjustment | | | – debit valuation adjustment | | | – funding fair value adjustment | | | | | | | | | | | | | | | Inception profit (Day 1 P&L reserves) | | | | | |
|
Disclosure of the effect of changes in significant unobservable assumptions to reasonably possible alternatives, assets |
| | | | | | | | | Sensitivity of Level 3 fair values to reasonably possible alternative assumptions | | | | | | | Reflected in profit or loss | | Reflected in profit or loss | | | | | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Derivatives, trading assets and trading liabilities are presented as one category to reflect the manner in which these instruments are risk managed. | | | | | | | | | Sensitivity of Level 3 fair values to reasonably possible alternative assumptions by instrument type | | | | | | | Reflected in profit or loss | | Reflected in profit or loss | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Disclosure of the effect of changes in significant unobservable assumptions to reasonably possible alternatives, liabilities |
| | | | | | | | | Sensitivity of Level 3 fair values to reasonably possible alternative assumptions | | | | | | | Reflected in profit or loss | | Reflected in profit or loss | | | | | | | | | | | | | | | | | | | | Derivatives, trading assets and trading liabilities1 | | | | | | | | | Designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Derivatives, trading assets and trading liabilities are presented as one category to reflect the manner in which these instruments are risk managed. | | | | | | | | | Sensitivity of Level 3 fair values to reasonably possible alternative assumptions by instrument type | | | | | | | Reflected in profit or loss | | Reflected in profit or loss | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Disclosure of significant unobservable inputs used in fair value measurement of assets |
| | | | | | | | | Quantitative information about significant unobservable inputs in Level 3 valuations | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments1 | | | | | | | | | Asset-backed securities (‘ABS’) | | | | | | | | | – collateralised loan/debt obligation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate derivatives: | | | | | | | | | | | | Model-Discounted cash flow | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – long-dated single stock options | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – other credit derivatives | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Model-Discounted cash flow | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Private equity including strategic investments’ includes private equity, private credit, private equity funds and infrastructure debt, primarily held as part of our Insurance business and for strategic investments.
|
Disclosure of significant unobservable inputs used in fair value measurement of liabilities |
| | | | | | | | | Quantitative information about significant unobservable inputs in Level 3 valuations | | | | | | | | | | | | | | | | | | | | | | | | Private equity including strategic investments1 | | | | | | | | | Asset-backed securities (‘ABS’) | | | | | | | | | – collateralised loan/debt obligation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate derivatives: | | | | | | | | | | | | Model-Discounted cash flow | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – long-dated single stock options | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | – other credit derivatives | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Model-Discounted cash flow | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
1Private equity including strategic investments’ includes private equity, private credit, private equity funds and infrastructure debt, primarily held as part of our Insurance business and for strategic investments.
|